Peptidomimetic antagonists designed to inhibit the binding of CD4 to HIV GP120.
Attempts to enhance the efficacy of our previously reported CD4 CDR2-like (residues 40-45) mimetic 1 by incorporation of the critical guanidine residue Arg-59 of CD4 are described.